A newly developed molecular imaging technique can identify multiple subtypes of triple-negative breast cancer (TNBC), ...

The Kenyan government has called for a radical transformation in the country’s health systems through the integration of ...

ACCURATE determination of HER-2 status in breast cancer is essential for guiding targeted therapy and improving clinical ...

Percutaneous coronary intervention to seal non–flow-limiting vulnerable plaques is associated with a lower incidence of cardiac outcomes, regardless of the patient’s diabetes status, a study finds.

A research group in Korea has discovered a novel natural antimicrobial peptide, "Hirunipin-2," from the salivary glands of ...

Notably, the ARCHES trial had the longest median follow-up among ARPI trials at 61.4 months. During this period, median overall survival was not reached in either treatment arm. At 5 years, 66% (two ...

A new study, sponsored by AstraZeneca and presented at the American Society of Clinical Oncology (ASCO) annual meeting in ...

Built for the Philips Azurion neuro biplane system, the latest generation of SmartCT simplifies and accelerates 3D imaging - ...

Cell-free DNA-based liquid biopsies showed promise for monitoring response to pancreatic cancer therapies and making ...

At a median follow-up of 60.7 months, patients in the combination arm of enzalutamide + leuprolide had significantly superior 5-year metastasis free survival rates (87.3% versus 71.4%; HR: 0.42, 95% ...

Pediatric rheumatology has seen significant advancements in the past decade, with new diagnostic tools and therapeutic approaches transforming patient care.